title: [Peritoneal disseminated recurrence after total gastrectomy for perforated gastric malignant lymphoma--a case report].
abstract: We reported a case of peritoneal disseminated recurrence after total gastrectomy for perforated gastric malignant lymphoma. A 73-year-old man underwent total gastrectomy for perforated gastric diffuse large B cell lymphoma on day 5 of RCHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisolone) chemotherapy. He has rejected chemotherapy and received no additional treatment after gastrectomy. Computer tomography 13 months after surgery revealed peritoneal dissemination and abdominal lymph node metastasis. R-CHOP chemotherapy was performed, and after 4 courses of chemotherapy, peritoneal dissemination and metastatic abdominal lymph nodes disappeared. Chemotherapy was discontinued for a time, however, the tumors relapsed 2 months after stopping chemotherapy. He underwent chemotherapy with etoposide, but died of tumor progression 21 months after gastrectomy.
authors.affiliation: Division of Gastric Surgery, Shizuoka Cancer Center.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tanizawa
authors.forename: Masanori
authors.initials: M
authors.lastname: Terashima
authors.forename: Masanori
authors.initials: M
authors.lastname: Tokunaga
authors.forename: Etsuro
authors.initials: E
authors.lastname: Bando
authors.forename: Taiichi
authors.initials: T
authors.lastname: Kawamura
authors.forename: Junya
authors.initials: J
authors.lastname: Kondo
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Waragai
authors.forename: Yoko
authors.initials: Y
authors.lastname: Motegi
authors.forename: Norihiko
authors.initials: N
authors.lastname: Sugisawa
authors.forename: Noriko
authors.initials: N
authors.lastname: Ohshima
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Taki
authors.forename: Rie
authors.initials: R
authors.lastname: Makuuchi
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Miki
authors.forename: Yushi
authors.initials: Y
authors.lastname: Yamakawa
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Kinugasa
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Kanemoto
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Uesaka
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Onozawa
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005743:Gastrectomy; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D008297:Male; D009366:Neoplasm Seeding; D010537:Peritoneum / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone